Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Indian Regulators Warn Companies Against “Unethical Promotion” Of Drugs To Doctors

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - India's drug price regulatory body, the National Pharmaceutical Pricing Authority, has come down heavily on perpetrators of "unethical promotion of drugs" to medical practitioners, adding that such moves push up drug prices, making them unaffordable to the masses

You may also be interested in...



India Pharma Industry Floats Ombudsman As Way To Curb Unfair Marketing Practices

Indian industry pushes for self-regulation in effort to ward off new regulations.

Indian Exporters Fume As EU Seizes Goods-In-Transit Claiming Patent Violations

MUMBAI - Large consignments of drug exports from India routed through the European Union are being confiscated on allegations of violation of local European patent laws. As per the EU patent laws, such exports are also termed as counterfeit drugs, experts say

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

UsernamePublicRestriction

Register

ID1130765

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel